Publications by authors named "Mathieu Uzzan"

Claim this Profile
P
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
Nicolas Mathieu, Marianne Hupé, Frédéric Heluwaert, Pauline Rivière, Xavier Hébuterne, Mathieu Uzzan

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor.
Aurélien Amiot, Julien Kirchgesner, Hadrien Alric, Xavier Tréton, Mathieu Uzzan

Clin Res Hepatol Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease.
Zlata Chkolnaia, Benedicte Lebrun-Vignes, Aurelien Amiot, Mathieu Uzzan, Nicolas Richard

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy.
Charlotte Larson, Jeffrey A Berinstein, Nicholas Tedesco, Jakob Benedict Seidelin, Pernille D Ovesen, Mathieu Uzzan

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of third-line advanced therapies in patients with ulcerative colitis: A multicentre retrospective cohort study: Third-line treatment in UC.
Anaïs Bertrand, Antoine Meyer, Julien Kirchgesner, Mathieu Uzzan, Vered Abitbol

Clin Res Hepatol Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Tommaso Innocenti, Jurij Hanžel, Marie Truyens, Milan Lukaš, Hannah Gordon, Mathieu Uzzan

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort.
Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, Sophie Hue, Pierre Wolkenstein, Mathieu Uzzan

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study.
Guillaume Le Cosquer, Julien Kirchgesner, Cyrielle Gilletta De Saint Joseph, Philippe Seksik, Aurélien Amiot, Mathieu Uzzan

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating checkpoint molecules in inflammatory bowel diseases as a new therapeutic strategy: a narrative review.
Zlata Chkolnaia, Walter Reinisch, Mathieu Uzzan

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
Pauline Wils, Romain Altwegg, Anthony Buisson, Lucine Vuitton, Stephane Nancey, Mathieu Uzzan

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study.
Mathilde Osty, Romain Altwegg, Mélanie Serrero, Alban Benezech, Albane Lecomte, Mathieu Uzzan

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A series of Sickle cell disease-associated inflammatory bowel diseases: high prevalence of colonic involvement and primary sclerosing cholangitis.
Julien Kirchgesner, Jeremy Augustin, Thomas Bazin, Pamela Freiha, Alexandre Nuzzo, Mathieu Uzzan

Clin Res Hepatol Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe enterocolitis associated with phosphatidylinositol 3-kinase delta inhibitors: A multicentre cohort study.
Marc Howaizi, Vered Abitbol, Mathieu Uzzan, Nassim Hammoudi, Jean-Marie Michot

Dig Liver Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: JAK to JAK-Navigating Intra-Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply.
Mathieu Uzzan, David Laharie, Julien Kirchgesner

Aliment Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.
Marie André, Julien Kirchgesner, David Laharie, Lucas Guillo, Philippe Seksik, Mathieu Uzzan

Am J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study.
Maria Cristina Conti Bellocchi, Martina Cattani Mottes, Andreas Blesl, Anneline Cremer, Stefano Festa, Mathieu Uzzan

Medicina (Kaunas)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).
Stéphane Vignes, Mathieu Uzzan, Lionel Arrivé, Françoise Le Pimpec-Barthes, Claire Fieschi

Orphanet J Rare Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis.
Sailish Honap, Joelle St-Pierre, Michael Colwill, Kamal Patel, Catherine Le Berre, Mathieu Uzzan

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1.
Torsten Kucharzik, Stuart Taylor, Mariangela Allocca, Johan Burisch, Pierre Ellul, Mathieu Uzzan

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2.
Henit Yanai, Roger Feakins, Mariangela Allocca, Johan Burisch, Pierre Ellul, Mathieu Uzzan

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus Kinase (JAK) Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study.
Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Mathieu Uzzan

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study.
Nicolas Richard, Aurélien Amiot, Philippe Seksik, Romain Altwegg, David Laharie, Mathieu Uzzan

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Toward Intra-Class Switching With JAK Inhibitors?
Mathieu Uzzan, David Laharie

Aliment Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease.
Sonia Tejedor Vaquero, Hadas Neuman, Laura Comerma, Xavi Marcos-Fa, Celia Corral-Vazquez, Mathieu Uzzan

J Exp Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal germinal center B cell depletion and reduction in IgA plasma cells in HIV-1 infection.
Francesca Cossarini, Joan Shang, Azra Krek, Zainab Al-Taie, Ruixue Hou, Mathieu Uzzan

Sci Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis